(Q47212247)

11 January 2018

title

Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience (English)

1 reference

11 January 2018

1 reference

1 reference

13

Gerken G

1 reference

11 January 2018

Tillmann HL

1

1 reference

11 January 2018

Hadem J

2

1 reference

11 January 2018

Leifeld L

3

1 reference

11 January 2018

Zachou K

4

1 reference

11 January 2018

Canbay A

5

1 reference

11 January 2018

Eisenbach C

6

1 reference

11 January 2018

Graziadei I

7

1 reference

11 January 2018

Encke J

8

1 reference

11 January 2018

Schmidt H

9

1 reference

11 January 2018

Vogel W

10

1 reference

11 January 2018

Schneider A

11

1 reference

11 January 2018

Spengler U

12

1 reference

11 January 2018

Dalekos GN

14

1 reference

11 January 2018

Wedemeyer H

15

1 reference

11 January 2018

Manns MP

16

1 reference

11 January 2018

publication date

1 April 2006

1 reference

11 January 2018

Journal of Viral Hepatitis

published in

1 reference

11 January 2018

volume

13

1 reference

11 January 2018

issue

4

1 reference

11 January 2018

page(s)

256-263

1 reference

11 January 2018

Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00695.X

Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00695.X

The treatment of chronic viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00695.X

Current state of interferon therapy in the treatment of chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00695.X

Effect of Am-80, a synthetic derivative of retinoid, on experimental arthritis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00695.X

Management of patients with decompensated HBV cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00695.X

Infection with GB virus C and reduced mortality among HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00695.X

Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00695.X

Lamivudine treatment for fulminant hepatic failure due to acute exacerbation of chronic hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00695.X

Successful lamivudine therapy for post-chemotherapeutic fulminant hepatitis B in a hepatitis B virus carrier with non-Hodgkin's lymphoma: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00695.X

The use of lamivudine for patients with acute hepatitis B (a series of cases).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00695.X

Lamivudine treatment for acute severe hepatitis B: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00695.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00695.X

10.1111/J.1365-2893.2005.00695.X

21 January 2018

Identifiers

DOI

1 reference

11 January 2018

1 reference

11 January 2018